Role of ser129 phosphorylation of α-synuclein in melanoma cells

Journal of Cell Science

Volumn 126, Issue 2, 2013, Pages 696-704

  Lee, Byung Rho ^a   Matsuo, Yasuhiro ^a,b   Cashikar, Anil G ^c   Kamitani, Tetsu ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b SHIMANE UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Synuclein; Melanoma; Parkinson's disease; Phosphorylation

Indexed keywords

ALPHA SYNUCLEIN; SERINE DERIVATIVE;

ANTIBODY RESPONSE; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; MELANOMA CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; EPITOPE MAPPING; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SERINE; SKIN NEOPLASMS;

EID: 84876083282     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.122093     Document Type: Article

References (45)

1. Ainsworth, S. K., Ito, S. and Karnovsky, M. J. (1972). Alkaline bismuth reagent for high resolution ultrastructural demonstration of periodate-reactive sites. J. Histochem. Cytochem. 20, 995-1005.
2. Alberio, T., Bossi, A. M., Milli, A., Parma, E., Gariboldi, M. B., Tosi, G., Lopiano, L. and Fasano, M. (2010). Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS J. 277, 4909-4919.
3. Alim, M. A., Ma, Q. L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M. et al. (2004). Demonstration of a role for α-synuclein as a functional microtubule-associated protein. J. Alzheimers Dis. 6, 435-442.
4. Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M. et al. (2006). Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752.
5. Auluck, P. K., Caraveo, G. and Lindquist, S. (2010). α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu. Rev. Cell Dev. Biol. 26, 211-233.
6. Bennett, M. C. (2005). The role of α-synuclein in neurodegenerative diseases. Pharmacol. Ther. 105, 311-331.
7. Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D., Abbruzzese, G. and Tabaton, M. (2000). Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 287, 65-67.
8. Chau, K. Y., Ching, H. L., Schapira, A. H. and Cooper, J. M. (2009). Relationship between a synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis. J. Neurochem. 110, 1005-1013.
9. El-Agnaf, O. M., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M., Ikeda, S. et al. (2003). asynuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 17, 1945-1947.
10. Fournier, M., Vitte, J., Garrigue, J., Langui, D., Dullin, J. P., Saurini, F., Hanoun, N., Perez-Diaz, F., Cornilleau, F., Joubert, C. et al. (2009). Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy. PLoS ONE 4, e6629.
11. Frost, B. and Diamond, M. I. (2010). Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159.
12. Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K. and Iwatsubo, T. (2002). α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160-164.
13. Gao, X., Simon, K. C., Han, J., Schwarzschild, M. A. and Ascherio, A. (2009). Family history of melanoma and Parkinson disease risk. Neurology 73, 1286-1291.
14. Golovko, M. Y., Faergeman, N. J., Cole, N. B., Castagnet, P. I., Nussbaum, R. L. and Murphy, E. J. (2005). α-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of α-synuclein palmitate binding. Biochemistry 44, 8251-8259.
15. Hansen, C., Angot, E., Bergström, A. L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K. et al. (2011). α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 121, 715-725.
16. Jakes, R., Crowther, R. A., Lee, V. M., Trojanowski, J. Q., Iwatsubo, T. and Goedert, M. (1999). Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci. Lett. 269, 13-16.
17. Kito, K., Yeh, E. T. H. and Kamitani, T. (2001). NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J. Biol. Chem. 276, 20603-20609.
18. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schöls, L. and Riess, O. (1998). Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
19. Lee, B. R. and Kamitani, T. (2011). Improved immunodetection of endogenous asynuclein. PLoS ONE 6, e23939.
20. Lee, H. J., Patel, S. and Lee, S. J. (2005). Intravesicular localization and exocytosis of α-synuclein and its aggregates. J. Neurosci. 25, 6016-6024.
21. Lee, S. J., Jeon, H. and Kandror, K. V. (2008). α-synuclein is localized in a subpopulation of rat brain synaptic vesicles. Acta Neurobiol. Exp. (Warsz.) 68, 509-515.
22. Lou, H., Montoya, S. E., Alerte, T. N., Wang, J., Wu, J., Peng, X., Hong, C. S., Friedrich, E. E., Mader, S. A., Pedersen, C. J. et al. (2010). Serine 129 phosphorylation reduces the ability of α-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J. Biol. Chem. 285, 17648-17661.
23. Maroteaux, L., Campanelli, J. T. and Scheller, R. H. (1988). Synuclein: a neuronspecific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
24. Matsuo, Y. and Kamitani, T. (2010). Parkinson's disease-related protein, α-synuclein, in malignant melanoma. PLoS ONE 5, e10481.
25. Matsuo, Y., Tanaka, K., Nakagawa, T., Matsuda, H. and Kawamukai, M. (2004). Genetic analysis of chs1+ and chs2+ encoding chitin synthases from Schizosaccharomyces pombe. Biosci. Biotechnol. Biochem. 68, 1489-1499.
26. McFarland, M. A., Ellis, C. E., Markey, S. P. and Nussbaum, R. L. (2008). Proteomics analysis identifies phosphorylation-dependent α-synuclein protein interactions. Mol. Cell. Proteomics 7, 2123-2137.
27. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C.-F., Chang, H.-M. and Yeh, E. T. H. (1996). Protection against Fas/APO-1-and tumor necrosis factormediated cell death by a novel protein, sentrin. J. Immunol. 157, 4277-4281.
28. Olanow, C. W. and McNaught, K. (2011). Parkinson's disease, proteins, and prions: milestones. Mov. Disord. 26, 1056-1071.
29. Olsen, J. H., Friis, S., Frederiksen, K., McLaughlin, J. K., Mellemkjaer, L. and Møller, H. (2005). Atypical cancer pattern in patients with Parkinson's disease. Br. J. Cancer 92, 201-205.
30. Olsen, J. H., Friis, S. and Frederiksen, K. (2006). Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 17, 582-587.
31. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997). Mutation in the asynuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
32. Pronin, A. N., Morris, A. J., Surguchov, A. and Benovic, J. L. (2000). Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275, 26515-26522.
33. Qing, H., Wong, W., McGeer, E. G. and McGeer, P. L. (2009). Lrrk2 phosphorylates a synuclein at serine 129: Parkinson disease implications. Biochem. Biophys. Res. Commun. 387, 149-152.
34. Rodriguez-Vicente, J., Vicente-Ortega, V. and Canteras-Jordana, (1996). Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines. Pigment Cell Res. 9, 317-325.
35. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003). α-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
36. Slot, J. W. and Geuze, H. J. (1985). A new method of preparing gold probes for multiple-labeling cytochemistry. Eur. J. Cell Biol. 38, 87-93.
37. Steiner, J. A., Angot, E. and Brundin, P. (2011). A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ. 18, 1425-1433.
38. Tanaka, M., Tanji, K., Niida, M. and Kamitani, T. (2010). Dynamic movements of Ro52 cytoplasmic bodies along microtubules. Histochem. Cell Biol. 133, 273-284.
39. Tanji, K., Tanaka, T., Mori, F., Kito, K., Takahashi, H., Wakabayashi, K. and Kamitani, T. (2006). NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am. J. Pathol. 169, 553-565.
40. Tanji, K., Mori, F., Kakita, A., Zhang, H., Kito, K., Kamitani, T., Takahashi, H. and Wakabayashi, K. (2007). Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol. 114, 365-371.
41. Tanji, K., Mori, F., Kito, K., Kakita, A., Mimura, J., Itoh, K., Takahashi, H., Kamitani, T. and Wakabayashi, K. (2011). Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease. J. Neuropathol. Exp. Neurol. 70, 879-889.
42. Utton, M. A., Noble, W. J., Hill, J. E., Anderton, B. H. and Hanger, D. P. (2005). Molecular motors implicated in the axonal transport of tau and α-synuclein. J. Cell Sci. 118, 4645-4654.
43. Volles, M. J. and Lansbury, P. T., Jr (2007). Relationships between the sequence of asynuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 366, 1510-1522.
44. Wang, Y., Shi, M., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., Srulijes, K., Trojanowski, J. Q., Lee, V. M., Siderowf, A. D. et al. (2012). Phosphorylated α Synuclein in Parkinson's Disease. Sci. Transl. Med. 4, 121.
45. Zarranz, J. J., Alegre, J., Gómez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B. et al. (2004). The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173.